APYX / Apyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call Transcript

Here is how Apyx Medical (APYX) and CymaBay Therapeutics Inc. (CBAY) have performed compared to their sector so far this year. more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q2 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Charles Goodwin - President & more_horizontal

Apyx Medical (APYX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to loss of more_horizontal

Here is how Apyx Medical (APYX) and Haemonetics (HAE) have performed compared to their sector so far this year. more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Charlie Goodwin - President & CE more_horizontal

Fintel reports that Archon Capital Management LLC has filed a 13G/A form with the SEC disclosing ownership of 3,452,030 shares of Apyx Medical Corp (A more_horizontal

Apyx Medical Corporation (NASDAQ:APYX ) Q3 2022 Earnings Conference Call November 10, 2022 8:00 AM ET Company Participants Charles Goodwin - President more_horizontal

The FDA has granted 510(k) clearance for Apyx Medical Corporation's (NASDAQ: APYX) Renuvion for subcutaneous dermatological and aesthetic procedur more_horizontal